With the use of a novel BRET-based sensor to monitor 14-3-3ζ:BAD interactions in living cells, we successfully identified terfenadine, penfluridol, and lomitapide as having the ability to disrupt 14-3-3ζ:BAD interactions and induce apoptosis of CRC cells. The gene discussed is BAD; the disease is colorectal carcinoma.